Preliminary results of a study comparing Atmo Biosciences’ novel ingestible gas-sensing capsule with a validated wireless motility capsule indicate that the Atmo capsule is a safe and promising tool to assess gut transit time.
Data from the Monash University comparative study, led by Professor Peter Gibson, was presented in a poster at the Meeting of the Federation of Neurogastroenterology & Motility (FNM 2020), held in Adelaide last week.